CodLiv
CodLiv, licence 80110027: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Britanica CodLiv
- Licence holder
- Britanica Medicines & Medical Equipment Ltd.
- NPN or DIN-HM
- 80110027
- Status
- Active licence
- Licence date
- 20 May 2021
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de foie de morue Source : Gadidae - Foie Potency : 50.0 mg Docosahexaenoic acid | 1000.0 mg | Not calculated |
| Huile de foie de morue Source : Gadidae - Foie Potency : 150.0 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de foie de morue Source : Gadidae - Foie Potency : 3.0 mcg Vitamin D | Not specified | Not calculated |
| Huile de foie de morue Source : Gadidae - Foie Potency : 140.0 mcg EAR Vitamin A | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones and teeth. Helps in the development and maintenance of night vision. Helps to maintain eyesight, skin membranes and immune function. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Source of vitamin A, a factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80110027
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.